A lawsuit was filed against CVS Health Corp (NYSE:CVS) over alleged inflating the price of generic prescriptions drugs sold to customers.
San Diego, CA -- (SBWIRE) -- 08/30/2017 -- The Shareholders Foundation announces that a consumer who used her insurance to purchased a generic durg at her local CVS filed a lawsuit against CVS Health Corp (NYSE:CVS) over so called clawbacks.
Those who used their insurance to purchase a generic drug at their local CVS pharmacy have certain options and should contact the the Shareholders Foundation at firstname.lastname@example.org or call 858-779-1554.
According to the complaint the consumer used her insurance to purchase a certain generic drug and was forced to pay significantly more what she would have been charged at the pharmacy if she would have paid cash. CVS allegedly never told the consumer that paying in cash would allow her to pay less for the same drug.
Furthermore, the consumer alleges that consumers are forced to pay pre-determined copays for medications even if the medications cost less at the cash price than the copays. The plaintiff says that the extra money goes to the pharmacy and some of it goes to the pharmacy benefit manager.
Those who used their insurance to purchase a generic drug at their local CVS pharmacy have certain options and should contact the have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels